UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 32 filers reported holding UROGEN PHARMA LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |